| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Alcohol Drinking | 67 | 2021 | 1663 | 16.02 | Why? |
| Alcoholic Beverages | 11 | 2021 | 186 | 5.09 | Why? |
| Alcoholism | 19 | 2021 | 691 | 3.97 | Why? |
| Fetal Alcohol Spectrum Disorders | 9 | 2019 | 21 | 3.79 | Why? |
| Ethanol | 11 | 2020 | 533 | 3.63 | Why? |
| Marijuana Abuse | 8 | 2021 | 111 | 2.70 | Why? |
| Substance-Related Disorders | 15 | 2021 | 2038 | 2.56 | Why? |
| Cannabis | 11 | 2021 | 284 | 2.27 | Why? |
| Medical Marijuana | 5 | 2018 | 55 | 2.24 | Why? |
| Driving Under the Influence | 3 | 2018 | 24 | 2.14 | Why? |
| Alcohol-Related Disorders | 6 | 2018 | 84 | 2.13 | Why? |
| Life Expectancy | 5 | 2019 | 474 | 2.10 | Why? |
| Marijuana Smoking | 8 | 2018 | 80 | 1.99 | Why? |
| Opioid-Related Disorders | 8 | 2019 | 1185 | 1.86 | Why? |
| Alcohol Abstinence | 4 | 2021 | 30 | 1.74 | Why? |
| Social Class | 6 | 2018 | 1360 | 1.74 | Why? |
| Public Policy | 6 | 2021 | 1894 | 1.72 | Why? |
| Cardiomyopathy, Alcoholic | 2 | 2018 | 6 | 1.46 | Why? |
| Accidents, Traffic | 3 | 2018 | 464 | 1.43 | Why? |
| Analgesics, Opioid | 6 | 2018 | 1070 | 1.30 | Why? |
| Global Burden of Disease | 3 | 2019 | 531 | 1.24 | Why? |
| Unsafe Sex | 3 | 2017 | 139 | 1.21 | Why? |
| Harm Reduction | 3 | 2017 | 392 | 1.09 | Why? |
| Taxes | 4 | 2019 | 66 | 1.06 | Why? |
| Condoms | 4 | 2018 | 235 | 1.01 | Why? |
| Blood Alcohol Content | 2 | 2018 | 9 | 0.95 | Why? |
| Prenatal Exposure Delayed Effects | 4 | 2019 | 319 | 0.91 | Why? |
| Health Surveys | 7 | 2020 | 2841 | 0.90 | Why? |
| Depressive Disorder, Major | 4 | 2018 | 852 | 0.90 | Why? |
| Binge Drinking | 3 | 2018 | 60 | 0.88 | Why? |
| Drug Overdose | 2 | 2018 | 583 | 0.87 | Why? |
| Wounds and Injuries | 3 | 2020 | 1708 | 0.86 | Why? |
| Underage Drinking | 2 | 2018 | 30 | 0.85 | Why? |
| Prescription Drug Misuse | 2 | 2018 | 54 | 0.81 | Why? |
| Health Status | 4 | 2017 | 3259 | 0.77 | Why? |
| Risk-Taking | 3 | 2018 | 508 | 0.75 | Why? |
| Health Policy | 6 | 2018 | 6242 | 0.75 | Why? |
| Alcohols | 1 | 2019 | 86 | 0.73 | Why? |
| Russia | 6 | 2019 | 989 | 0.71 | Why? |
| Criminals | 1 | 2018 | 56 | 0.71 | Why? |
| Ontario | 12 | 2019 | 1966 | 0.71 | Why? |
| Hypertension | 6 | 2018 | 8895 | 0.65 | Why? |
| Primary Health Care | 7 | 2021 | 4839 | 0.64 | Why? |
| Substance Abuse Detection | 2 | 2021 | 192 | 0.64 | Why? |
| Mood Disorders | 2 | 2018 | 431 | 0.64 | Why? |
| Drug and Narcotic Control | 1 | 2018 | 134 | 0.62 | Why? |
| Mortality, Premature | 1 | 2017 | 111 | 0.62 | Why? |
| Social Norms | 1 | 2018 | 240 | 0.62 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.61 | Why? |
| Fentanyl | 1 | 2017 | 142 | 0.61 | Why? |
| Canada | 12 | 2021 | 6018 | 0.60 | Why? |
| Mortality | 4 | 2019 | 7132 | 0.57 | Why? |
| Global Health | 9 | 2020 | 13911 | 0.56 | Why? |
| Risk Assessment | 12 | 2019 | 25439 | 0.56 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.56 | Why? |
| Acquired Immunodeficiency Syndrome | 2 | 2018 | 533 | 0.55 | Why? |
| Liver Cirrhosis, Alcoholic | 1 | 2014 | 32 | 0.55 | Why? |
| Commerce | 2 | 2021 | 1109 | 0.54 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.54 | Why? |
| Food Industry | 1 | 2016 | 197 | 0.52 | Why? |
| Health Services | 2 | 2017 | 765 | 0.52 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.52 | Why? |
| Humans | 125 | 2021 | 930598 | 0.52 | Why? |
| Intention | 3 | 2020 | 1380 | 0.51 | Why? |
| Preventive Health Services | 1 | 2018 | 501 | 0.48 | Why? |
| HIV Infections | 5 | 2018 | 11620 | 0.47 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.46 | Why? |
| Socioeconomic Factors | 8 | 2021 | 8495 | 0.46 | Why? |
| Prevalence | 22 | 2019 | 25773 | 0.46 | Why? |
| Psychotropic Drugs | 1 | 2016 | 396 | 0.45 | Why? |
| Social Stigma | 2 | 2018 | 1049 | 0.45 | Why? |
| Psychological Theory | 1 | 2014 | 226 | 0.45 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.44 | Why? |
| Disabled Persons | 3 | 2019 | 1152 | 0.44 | Why? |
| Behavior, Addictive | 1 | 2018 | 535 | 0.43 | Why? |
| Female | 74 | 2021 | 380317 | 0.43 | Why? |
| World Health Organization | 4 | 2019 | 4213 | 0.43 | Why? |
| Cardiomyopathies | 2 | 2017 | 997 | 0.42 | Why? |
| Population Health | 1 | 2017 | 504 | 0.42 | Why? |
| Policy Making | 1 | 2018 | 829 | 0.42 | Why? |
| Automobile Driving | 3 | 2018 | 222 | 0.42 | Why? |
| Wine | 1 | 2010 | 57 | 0.41 | Why? |
| Psychotherapy | 1 | 2018 | 747 | 0.41 | Why? |
| Disinfectants | 1 | 2020 | 1077 | 0.40 | Why? |
| Risk Factors | 21 | 2020 | 71621 | 0.40 | Why? |
| Adult | 55 | 2021 | 244371 | 0.40 | Why? |
| Male | 65 | 2021 | 367725 | 0.40 | Why? |
| Cost of Illness | 2 | 2019 | 1903 | 0.39 | Why? |
| Cause of Death | 6 | 2019 | 4823 | 0.39 | Why? |
| Cardiovascular System | 1 | 2017 | 750 | 0.38 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.38 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.37 | Why? |
| Noncommunicable Diseases | 1 | 2018 | 934 | 0.36 | Why? |
| Brain Injuries, Traumatic | 3 | 2017 | 381 | 0.35 | Why? |
| Critical Pathways | 1 | 2018 | 1587 | 0.35 | Why? |
| South Africa | 4 | 2018 | 3326 | 0.34 | Why? |
| Guidelines as Topic | 2 | 2017 | 2844 | 0.33 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.33 | Why? |
| Adolescent | 32 | 2021 | 86841 | 0.33 | Why? |
| Regression Analysis | 4 | 2018 | 2484 | 0.33 | Why? |
| Marijuana Use | 2 | 2018 | 89 | 0.33 | Why? |
| Poverty | 2 | 2018 | 2302 | 0.32 | Why? |
| Interrupted Time Series Analysis | 2 | 2021 | 868 | 0.32 | Why? |
| Young Adult | 28 | 2021 | 93724 | 0.32 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.32 | Why? |
| Students | 4 | 2020 | 5255 | 0.32 | Why? |
| Middle Aged | 45 | 2021 | 270681 | 0.30 | Why? |
| Patient Care Management | 1 | 2017 | 1514 | 0.30 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.30 | Why? |
| Quality-Adjusted Life Years | 2 | 2019 | 511 | 0.30 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.29 | Why? |
| Latin America | 3 | 2021 | 1721 | 0.29 | Why? |
| Cross-Sectional Studies | 19 | 2021 | 53120 | 0.28 | Why? |
| European Union | 2 | 2018 | 565 | 0.26 | Why? |
| Costs and Cost Analysis | 2 | 2019 | 694 | 0.26 | Why? |
| Pregnancy | 12 | 2019 | 23879 | 0.25 | Why? |
| Smoking | 5 | 2018 | 3358 | 0.24 | Why? |
| Europe | 5 | 2021 | 12702 | 0.24 | Why? |
| Public Health | 6 | 2018 | 16359 | 0.23 | Why? |
| Alcoholics | 1 | 2021 | 24 | 0.23 | Why? |
| Consumer Behavior | 2 | 2019 | 544 | 0.23 | Why? |
| Cohort Studies | 9 | 2021 | 36005 | 0.22 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Motivation | 1 | 2012 | 1640 | 0.22 | Why? |
| Conduct Disorder | 2 | 2017 | 39 | 0.22 | Why? |
| Alcoholic Intoxication | 2 | 2021 | 77 | 0.21 | Why? |
| Dronabinol | 2 | 2017 | 89 | 0.20 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.20 | Why? |
| Age Distribution | 3 | 2018 | 3567 | 0.20 | Why? |
| Caribbean Region | 2 | 2018 | 349 | 0.20 | Why? |
| Mental Health Services | 1 | 2017 | 3007 | 0.20 | Why? |
| Survival Rate | 3 | 2018 | 9206 | 0.19 | Why? |
| Hallucinogens | 1 | 2018 | 12 | 0.19 | Why? |
| Sodium Oxybate | 1 | 2018 | 14 | 0.19 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.19 | Why? |
| Magnetic Resonance Spectroscopy | 2 | 2017 | 881 | 0.19 | Why? |
| Dysthymic Disorder | 1 | 2018 | 7 | 0.19 | Why? |
| Alcohol Deterrents | 1 | 2018 | 24 | 0.19 | Why? |
| Longitudinal Studies | 8 | 2018 | 9893 | 0.18 | Why? |
| Quality of Life | 4 | 2020 | 9820 | 0.18 | Why? |
| Crack Cocaine | 1 | 2017 | 8 | 0.18 | Why? |
| Wales | 1 | 2021 | 758 | 0.18 | Why? |
| Smoking Devices | 1 | 2017 | 3 | 0.18 | Why? |
| Ecological and Environmental Phenomena | 1 | 2017 | 25 | 0.18 | Why? |
| Sex Factors | 5 | 2018 | 11014 | 0.18 | Why? |
| Hepatitis C, Chronic | 2 | 2017 | 973 | 0.17 | Why? |
| Estonia | 1 | 2017 | 59 | 0.17 | Why? |
| Tobacco Smoke Pollution | 1 | 2020 | 181 | 0.17 | Why? |
| Naltrexone | 1 | 2017 | 56 | 0.17 | Why? |
| Bipolar Disorder | 2 | 2017 | 744 | 0.17 | Why? |
| Legislation, Drug | 1 | 2018 | 101 | 0.17 | Why? |
| Tobacco Use | 1 | 2020 | 340 | 0.17 | Why? |
| Cocaine-Related Disorders | 1 | 2017 | 51 | 0.17 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.17 | Why? |
| Scotland | 1 | 2021 | 1119 | 0.16 | Why? |
| Risk | 3 | 2018 | 5288 | 0.16 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 159 | 0.16 | Why? |
| Anxiety | 3 | 2021 | 17311 | 0.16 | Why? |
| Aggression | 1 | 2017 | 126 | 0.16 | Why? |
| Pharmaceutical Preparations | 2 | 2021 | 1897 | 0.16 | Why? |
| Marketing | 1 | 2018 | 195 | 0.16 | Why? |
| Gross Domestic Product | 1 | 2017 | 134 | 0.16 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.15 | Why? |
| International Classification of Diseases | 1 | 2019 | 265 | 0.15 | Why? |
| Factor Analysis, Statistical | 1 | 2018 | 538 | 0.15 | Why? |
| Causality | 2 | 2017 | 857 | 0.15 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.15 | Why? |
| Fraud | 1 | 2017 | 116 | 0.15 | Why? |
| Hungary | 1 | 2017 | 491 | 0.15 | Why? |
| Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 441 | 0.15 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.14 | Why? |
| Fertility | 1 | 2019 | 367 | 0.14 | Why? |
| Habits | 1 | 2017 | 334 | 0.14 | Why? |
| Cannabinoids | 1 | 2017 | 134 | 0.14 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.14 | Why? |
| Finland | 1 | 2017 | 671 | 0.14 | Why? |
| Health Services Accessibility | 2 | 2018 | 10697 | 0.14 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.14 | Why? |
| Surveys and Questionnaires | 13 | 2021 | 43792 | 0.14 | Why? |
| Comorbidity | 11 | 2021 | 34796 | 0.14 | Why? |
| Methadone | 1 | 2017 | 296 | 0.13 | Why? |
| Age Factors | 5 | 2020 | 21039 | 0.13 | Why? |
| Prescription Drugs | 1 | 2017 | 243 | 0.13 | Why? |
| Aged | 18 | 2021 | 215776 | 0.13 | Why? |
| Sex Distribution | 2 | 2018 | 2083 | 0.13 | Why? |
| Suicide, Attempted | 1 | 2020 | 599 | 0.13 | Why? |
| United States | 7 | 2018 | 46150 | 0.13 | Why? |
| Medicaid | 1 | 2018 | 492 | 0.13 | Why? |
| Mental Disorders | 5 | 2018 | 6742 | 0.12 | Why? |
| Spain | 7 | 2021 | 15545 | 0.12 | Why? |
| Family Health | 1 | 2018 | 731 | 0.12 | Why? |
| Affect | 1 | 2018 | 549 | 0.12 | Why? |
| Sexual Partners | 1 | 2017 | 612 | 0.12 | Why? |
| Incidence | 4 | 2018 | 25622 | 0.12 | Why? |
| Thailand | 1 | 2016 | 1155 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.11 | Why? |
| Ireland | 1 | 2017 | 1456 | 0.11 | Why? |
| Video Recording | 1 | 2017 | 786 | 0.11 | Why? |
| Odds Ratio | 3 | 2020 | 5861 | 0.11 | Why? |
| Mass Screening | 3 | 2021 | 8005 | 0.11 | Why? |
| Buprenorphine | 1 | 2017 | 470 | 0.11 | Why? |
| Protective Factors | 1 | 2017 | 1720 | 0.11 | Why? |
| Suicidal Ideation | 1 | 2020 | 1226 | 0.11 | Why? |
| Opiate Substitution Treatment | 1 | 2017 | 613 | 0.11 | Why? |
| Taste | 2 | 2017 | 715 | 0.10 | Why? |
| Government Regulation | 1 | 2017 | 842 | 0.10 | Why? |
| Health Expenditures | 1 | 2017 | 904 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.10 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.10 | Why? |
| Policy | 1 | 2018 | 1372 | 0.10 | Why? |
| Self Report | 2 | 2018 | 3802 | 0.09 | Why? |
| Poland | 1 | 2017 | 2368 | 0.09 | Why? |
| Autism Spectrum Disorder | 1 | 2017 | 587 | 0.09 | Why? |
| Homosexuality, Male | 1 | 2017 | 1158 | 0.09 | Why? |
| Spectrum Analysis, Raman | 1 | 2010 | 311 | 0.09 | Why? |
| General Practice | 1 | 2017 | 718 | 0.09 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.09 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.08 | Why? |
| Data Interpretation, Statistical | 1 | 2012 | 657 | 0.08 | Why? |
| Leadership | 1 | 2021 | 2241 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Logistic Models | 5 | 2020 | 9089 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Child | 8 | 2020 | 70012 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.08 | Why? |
| Germany | 2 | 2021 | 9196 | 0.07 | Why? |
| Time Factors | 3 | 2018 | 31397 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.07 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.07 | Why? |
| Linear Models | 1 | 2012 | 1914 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.07 | Why? |
| Anxiety Disorders | 1 | 2018 | 2290 | 0.07 | Why? |
| Forecasting | 1 | 2019 | 4492 | 0.07 | Why? |
| Occupational Exposure | 2 | 2020 | 4742 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Mental Health | 4 | 2021 | 15770 | 0.07 | Why? |
| Health Resources | 1 | 2017 | 2592 | 0.07 | Why? |
| Dementia | 1 | 2018 | 1861 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.07 | Why? |
| Aged, 80 and over | 7 | 2019 | 88759 | 0.07 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Schools | 1 | 2019 | 4187 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Emergency Service, Hospital | 2 | 2018 | 14232 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2018 | 3419 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.06 | Why? |
| Lithuania | 1 | 2021 | 92 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Disease Progression | 2 | 2017 | 13580 | 0.05 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.05 | Why? |
| Czech Republic | 1 | 2021 | 307 | 0.05 | Why? |
| Depression | 2 | 2021 | 14116 | 0.05 | Why? |
| Cocarcinogenesis | 1 | 2018 | 4 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.05 | Why? |
| United Kingdom | 1 | 2019 | 18046 | 0.05 | Why? |
| International Agencies | 1 | 2020 | 202 | 0.05 | Why? |
| Italy | 3 | 2018 | 38444 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Neoplasms, Radiation-Induced | 1 | 2018 | 60 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.04 | Why? |
| Patient Health Questionnaire | 1 | 2020 | 625 | 0.04 | Why? |
| Heroin Dependence | 1 | 2017 | 37 | 0.04 | Why? |
| Norway | 1 | 2021 | 1004 | 0.04 | Why? |
| Peru | 1 | 2021 | 1010 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Colombia | 1 | 2021 | 1241 | 0.04 | Why? |
| Motor Vehicles | 1 | 2017 | 223 | 0.04 | Why? |
| Cannabidiol | 1 | 2017 | 138 | 0.04 | Why? |
| Problem Behavior | 1 | 2016 | 176 | 0.03 | Why? |
| Developed Countries | 1 | 2018 | 500 | 0.03 | Why? |
| Kenya | 1 | 2017 | 887 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.03 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.03 | Why? |
| Mexico | 1 | 2021 | 2787 | 0.03 | Why? |
| Neurodevelopmental Disorders | 1 | 2017 | 284 | 0.03 | Why? |
| France | 2 | 2018 | 12074 | 0.03 | Why? |
| Depressive Disorder | 1 | 2021 | 1236 | 0.03 | Why? |
| Overweight | 1 | 2017 | 916 | 0.03 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Emigrants and Immigrants | 1 | 2017 | 888 | 0.02 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.02 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.02 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.02 | Why? |
| Diet | 1 | 2018 | 2052 | 0.02 | Why? |
| Child, Preschool | 3 | 2017 | 36283 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Long-Term Care | 1 | 2017 | 2047 | 0.02 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.02 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Parents | 1 | 2017 | 2758 | 0.02 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.01 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Infant | 2 | 2017 | 30274 | 0.01 | Why? |
| Coronary Disease | 1 | 2005 | 645 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| New Zealand | 1 | 2005 | 2073 | 0.01 | Why? |
| Demography | 1 | 2004 | 1660 | 0.01 | Why? |
| Switzerland | 1 | 2004 | 2738 | 0.01 | Why? |
| International Cooperation | 1 | 2008 | 3436 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |